GL1X · GenesisL1 explorer

Ligand · L0G

L0G · 2-{4-[(cyclopropylcarbamoyl)amino]-1H-pyrazol-3-yl}-6-(morpholin-4-ium-4-ylmethyl)-1H-3,1-benzimidazol-3-ium

L0G, 2-{4-[(cyclopropylcarbamoyl)amino]-1H-pyrazol-3-yl}-6-(morpholin-4-ium-4-ylmethyl)-1H-3,1-benzimidazol-3-ium (C19 H25 N7 O2 +2, 383.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
L0G
Formula
C19 H25 N7 O2 +2
Class
ligand
Structures
2
PDB entries
1

Binding sites

L0G in 2 structures; the first of them:

  • 2W1G · Structure determination of Aurora Kinase in complex with inhibitor · L0G A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 9 more
  • 2W1G · Structure determination of aurora kinase in complex with inhibitor · L0G A1390 · binds ARG137, LEU139, GLY140, LYS141, VAL147, ALA160, LYS162, LEU194 and 9 more

Residues it binds most

LEU 2, ALA 2, GLY 2, LYS 2, ARG 2, GLU 2, PRO 2, THR 2, TYR 2, VAL 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.